Your browser doesn't support javascript.
loading
Claudin-5 is associated with elevated TATI and CA125 levels in mucinous ovarian borderline tumors.
Nissi, Ritva; Talvensaari-Mattila, Anne; Kuvaja, Paula; Pääkkö, Paavo; Soini, Ylermi; Santala, Markku.
Afiliação
  • Nissi R; Department of Obstetrics and Gynecology, Oulu University Hospital, Oulu, Finland ritva-kaarina.nissi@ouka.fi.
  • Talvensaari-Mattila A; Department of Obstetrics and Gynecology, Oulu University Hospital, Oulu, Finland.
  • Kuvaja P; Department of Anatomy and Cell Biology, Institute of Biomedicine, University of Oulu, Oulu, Finland Department of Pathology, Institute of Diagnostics, Oulu University Hospital, Oulu, Finland.
  • Pääkkö P; Department of Pathology, Institute of Diagnostics, Oulu University Hospital, Oulu, Finland.
  • Soini Y; Department of Pathology and Forensic Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, School of Medicine, University of Eastern Finland, Cancer Center of Eastern Finland, Kuopio, Finland.
  • Santala M; Department of Obstetrics and Gynecology, Oulu University Hospital, Oulu, Finland.
Anticancer Res ; 35(2): 973-6, 2015 Feb.
Article em En | MEDLINE | ID: mdl-25667483
Assuntos
Palavras-chave
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Inibidor da Tripsina Pancreática de Kazal / Adenocarcinoma Mucinoso / Antígeno Ca-125 / Claudina-5 Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Inibidor da Tripsina Pancreática de Kazal / Adenocarcinoma Mucinoso / Antígeno Ca-125 / Claudina-5 Idioma: En Ano de publicação: 2015 Tipo de documento: Article